Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 2065258

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 2065258

Fertility Market Size, Share, and Growth Analysis, By Treatment Type, By Product & Service Type, By Procedure Type, By Patient Type, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Fertility Market size was valued at USD 32.30 Billion in 2024 and is poised to grow from USD 35.10 Billion in 2025 to USD 68.32 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The global fertility market is experiencing significant growth, driven by demographic changes such as delayed childbearing and rising infertility rates. This sector encompasses assisted reproductive technologies, diagnostics, pharmaceuticals, and donor services, which collectively enhance individuals' and couples' chances of conception. Innovations like pre-implantation genetic testing (PGT) and advanced embryo freezing techniques have improved clinical outcomes, consequently expanding the market as success rates and cumulative cost efficiencies rise. Additionally, corporate fertility benefits and egg freezing programs have attracted career-focused women, particularly in urban settings. Fertility tourism is also on the rise, with individuals traveling to countries offering affordable and advanced fertility solutions, fostering international collaboration and investment in fertility-related technologies, data analytics, and customized treatment protocols.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fertility market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fertility Market Segments Analysis

Global fertility market is segmented by treatment type, product & service type, procedure type, patient type, end user, distribution channel and region. Based on treatment type, the market is segmented into assisted reproductive technology (ART), artificial insemination, fertility preservation and fertility drugs & hormonal therapy. Based on product & service type, the market is segmented into fertility drugs, fertility consumables & media, fertility equipment, fertility testing & diagnostics and fertility clinic services. Based on procedure type, the market is segmented into fresh non-donor cycles, frozen non-donor cycles, donor egg cycles, donor embryo cycles and gestational carrier cycles. Based on patient type, the market is segmented into female infertility, male infertility, combined infertility, unexplained infertility and single parents & LGBTQ+ families. Based on end user, the market is segmented into fertility clinics, hospitals, surgical centers, cryobanks & fertility preservation centers and research institutes. Based on distribution channel, the market is segmented into direct tender & institutional sales, retail pharmacies, specialty pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fertility Market

The increasing prevalence of infertility has led to a greater demand for diagnostic, therapeutic, and supportive fertility services, resulting in a larger number of individuals seeking assistance. This surge in need encourages clinics and laboratories to enhance their capabilities and broaden their treatment offerings to cater to diverse patient needs. Furthermore, healthcare providers are prioritizing investments in advanced technology and specialized training to boost success rates, ultimately drawing in more patients and prompting them to seek medical advice sooner. This ongoing trend fosters robust market demand, leading to continuous utilization of related products, procedures, and services throughout various regions.

Restraints in the Global Fertility Market

The high expenses related to fertility treatments create significant barriers for many individuals, restricting access and limiting overall market growth. When patients face substantial out-of-pocket costs and inadequate insurance coverage, the affordability of these services diminishes, leading to demand primarily from wealthier demographics. This concentration of demand hampers widespread utilization and results in slower adoption of fertility treatments. Additionally, elevated costs may discourage timely intervention, prompting potential patients to delay or abandon their treatment plans, ultimately impacting long-term service availability. Consequently, this situation restricts market expansion by reducing the customer base and impeding consistent growth across various regions.

Market Trends of the Global Fertility Market

The global fertility market is increasingly embracing digital and telehealth integration, significantly transforming the delivery of reproductive healthcare services. Virtual consultations and remote monitoring capabilities are enabling continuous patient engagement and personalized treatment experiences, while enhancing access for individuals in remote areas. The incorporation of electronic health records and interoperable data fosters seamless coordination among healthcare providers, streamlining clinical decision-making and follow-up processes. This shift not only redefines clinic workflows but also necessitates the development of new staff competencies that align with a patient-centric approach. Ultimately, these innovations pave the way for differentiated offerings that emphasize convenience, transparency, and nurturing therapeutic relationships.

Product Code: SQMIG35D2475

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Fertility Market Size by Treatment Type & CAGR (2026-2033)

  • Market Overview
  • Assisted Reproductive Technology (ART)
    • In Vitro Fertilization (IVF)
    • Intracytoplasmic Sperm Injection (ICSI)
    • Frozen Embryo Transfer (FET)
    • Donor Egg & Donor Sperm Procedures
    • Surrogacy Services
  • Artificial Insemination
    • Intrauterine Insemination (IUI)
    • Intracervical Insemination (ICI)
  • Fertility Preservation
    • Egg Freezing
    • Sperm Freezing
    • Embryo Cryopreservation
  • Fertility Drugs & Hormonal Therapy
    • Ovulation Induction Drugs
    • Gonadotropins
    • Hormonal Support Therapy

Global Fertility Market Size by Product & Service Type & CAGR (2026-2033)

  • Market Overview
  • Fertility Drugs
  • Fertility Consumables & Media
  • Fertility Equipment
    • Imaging Systems
    • Incubators
    • Micromanipulation Systems
    • Cryopreservation Systems
  • Fertility Testing & Diagnostics
  • Fertility Clinic Services

Global Fertility Market Size by Procedure Type & CAGR (2026-2033)

  • Market Overview
  • Fresh Non-Donor Cycles
  • Frozen Non-Donor Cycles
  • Donor Egg Cycles
  • Donor Embryo Cycles
  • Gestational Carrier Cycles

Global Fertility Market Size by Patient Type & CAGR (2026-2033)

  • Market Overview
  • Female Infertility
  • Male Infertility
  • Combined Infertility
  • Unexplained Infertility
  • Single Parents & LGBTQ+ Families

Global Fertility Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Cryobanks & Fertility Preservation Centers
  • Research Institutes

Global Fertility Market Size by Distribution Channel & CAGR (2026-2033)

  • Market Overview
  • Direct Tender & Institutional Sales
  • Retail Pharmacies
  • Specialty Pharmacies
  • Online Pharmacies

Global Fertility Market Size & CAGR (2026-2033)

  • North America (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
    • US
    • Canada
  • Europe (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • CooperSurgical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitrolife Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FUJIFILM Irvine Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Thorne
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kitazato Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Esco Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genea Biomedx
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Progyny
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IVI RMA Global
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virtus Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monash IVF Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ferring Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Organon
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gedeon Richter
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bloom IVF Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Apollo Fertility
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gaudium IVF
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!